Mastodawn

Scientific European Apr 7, 2024

Antibiotic Zevtera (Ceftobiprole medocaril) approved by FDA for treatment of CABP, ABSSSI and SAB
The broad-spectrum fifth-generation cephalosporin antibiotic, Zevtera (Ceftobiprole medocaril sodium Inj.)...........
#ABSSSI #Antibiotic #BroadSpectrum #CABP #Ceftobiprolemedocaril #cephalosporin #FDA #pneumonia #SAB #Staphylococcusaureus #Zevtera
SCIE

https://www.scientificeuropean.co.uk/medicine/antibiotic-zevtera-ceftobiprole-medocaril-approved-by-fda-for-treatment-of-cabp-absssi-and-sab/

Antibiotic Zevtera (Ceftobiprole medocaril) approved by FDA for treatment of CABP, ABSSSI and SAB

The broad-spectrum fifth-generation cephalosporin antibiotic, Zevtera (Ceftobiprole medocaril sodium Inj.) has been approved by FDA1 for the treatment of thre

Scientific European